A listing of ctsi-central-admin medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This study is being done to learn more about the safety and effects of the combination of Lumacaftor (LUM) and Ivacaftor (IVA) in patients with Cystic Fibrosis between 1 to less than 2 years of age.
The purpose of this study is to see if Daratumumab is useful for treating pediatric (subjects aged >=1 to 18 years) and young adult patients (aged 18 to 30 years) with acute lymphoblastic leukemia or lymphoblastic lymphoma.
This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair.
This study is designed to investigate whether the use of copanlisib is safe, feasible and beneficial to pediatric patients with solid solid tumors or lymphoma that are recurrent or refractory to standard therapy.
The purpose of this study is to find out if PET can detect the release of dopamine from nerve endings into synapses, and how the amount of dopamine released varies with the consumption of alcohol or caffeine.
The purpose of this study is to investigate different aspects of time perception and explore how these functions relate to cognition, personality, and cerebellar function.
The purpose of this study is to evaluate the safety and effectiveness of an intraocular (IOL) lens called the ARTISAN? Aphakia Lens for the correction of aphakia.
The purpose of this Phase II Study is to determine the response rate of NFI patients with plexiform neurofibromas treated with Cabozantinib therapy using MRI scans.
The purpose of this study is to establish a recruitment database of individuals who have contacted the research staff in the department of dermatology expressing interest in participating in clinical research and requesting to be contacted if eligible to participate. 800x600 Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4